← Back to All US Stocks

Healthcare Triangle, Inc. (HCTI) Stock Fundamental Analysis & AI Rating 2026

HCTI Nasdaq Services-Computer Integrated Systems Design DE CIK: 0001839285
Recently Updated • Analysis: May 21, 2026 • SEC Data: 2026-03-31
Combined AI Rating
STRONG SELL
80% Confidence
STRONG AGREEMENT
STRONG SELL
97% Conf
STRONG SELL
64% Conf

📊 HCTI Key Takeaways

Revenue: $9.9M
Net Margin: -62.9%
Free Cash Flow: $-6.9M
Current Ratio: 0.90x
Debt/Equity: 0.16x
EPS: $-6.81
AI Rating: STRONG SELL with 97% confidence
Healthcare Triangle, Inc. (HCTI) receives a STRONG SELL rating with 80% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $9.9M, net profit margin of -62.9%, and return on equity (ROE) of -11.8%, Healthcare Triangle, Inc. demonstrates mixed fundamentals in the Technology sector. Below is our complete HCTI stock analysis for 2026.

Is Healthcare Triangle, Inc. (HCTI) a Good Investment?

Claude

Healthcare Triangle exhibits severe financial distress with persistent operating losses (-$3.6M), negative operating cash flow (-$6.9M), and deteriorating liquidity (current ratio 0.90x). The company is burning cash with minimal runway remaining ($4.3M in cash), unable to generate positive returns or cover interest obligations from operations, indicating elevated default risk.

ChatGPT

Despite hypergrowth, HCTI remains structurally unprofitable with deeply negative operating and free cash flow and a cash balance that appears insufficient relative to burn, implying urgent financing needs and dilution risk. Reported gross profit/margin figures are inconsistent with revenue levels and likely reflect non-recurring or data classification effects, masking weak underlying unit economics.

Why Buy Healthcare Triangle, Inc. Stock? HCTI Key Strengths

Claude
  • + Moderate leverage with Debt/Equity ratio of 0.16x provides some financial flexibility
  • + Positive stockholders equity of $52.7M provides a capital cushion above liabilities
  • + Operating in growing healthcare IT systems integration sector with structural demand
ChatGPT
  • + Triple-digit revenue growth from a low base
  • + Low leverage (0.10x D/E) reduces solvency risk
  • + Current ratio >2.0x provides short-term liquidity cushion

HCTI Stock Risks: Healthcare Triangle, Inc. Investment Risks

Claude
  • ! Severe liquidity crisis: current ratio of 0.90x indicates inability to cover short-term obligations; negative operating cash flow of -$6.9M indicates rapid cash depletion with estimated 6-12 month runway
  • ! Persistent unprofitability across all levels: operating loss of -$3.6M, net loss of -$6.2M, negative interest coverage of -40.7x indicates inability to service debt from operations
  • ! Deteriorating operational performance: negative gross margin anomaly and sustained losses suggest fundamental business model dysfunction or severe underperformance; no insider purchases in 90 days suggests loss of confidence
ChatGPT
  • ! Severe cash burn vs. $1.63M cash implies short runway
  • ! Persistent negative margins and returns (ROE/ROA) indicate weak economics
  • ! Gross profit anomaly suggests one-time items or data issues

Key Metrics to Watch

Claude
  • * Quarterly cash burn rate and remaining cash runway; path to positive operating cash flow
  • * Revenue growth and operating margin trajectory; achievement of operational breakeven
  • * Covenant compliance and refinancing risk on $8.5M long-term debt; potential default events
ChatGPT
  • * Operating cash flow (quarterly trend and burn)
  • * Cash balance and runway vs. financing needs

Healthcare Triangle, Inc. (HCTI) Financial Metrics & Key Ratios

Revenue
$9.9M
Net Income
$-6.2M
EPS (Diluted)
$-6.81
Free Cash Flow
$-6.9M
Total Assets
$80.2M
Cash Position
$4.3M

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

HCTI Profit Margin, ROE & Profitability Analysis

Gross Margin 12,531.7%
Operating Margin -36.8%
Net Margin -62.9%
ROE -11.8%
ROA -7.7%
FCF Margin -69.9%

HCTI vs Technology Sector: How Healthcare Triangle, Inc. Compares

How Healthcare Triangle, Inc. compares to Technology sector averages

Net Margin
HCTI -62.9%
vs
Sector Avg 18.0%
HCTI Sector
ROE
HCTI -11.8%
vs
Sector Avg 22.0%
HCTI Sector
Current Ratio
HCTI 0.9x
vs
Sector Avg 2.5x
HCTI Sector
Debt/Equity
HCTI 0.2x
vs
Sector Avg 0.5x
HCTI Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Healthcare Triangle, Inc. Stock Overvalued? HCTI Valuation Analysis 2026

Based on fundamental analysis, Healthcare Triangle, Inc. has mixed fundamental signals relative to the Technology sector in 2026.

Return on Equity
-11.8%
Sector avg: 22%
Net Profit Margin
-62.9%
Sector avg: 18%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.16x
Sector avg: 0.5x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Healthcare Triangle, Inc. Balance Sheet: HCTI Debt, Cash & Liquidity

Current Ratio
0.90x
Quick Ratio
0.90x
Debt/Equity
0.16x
Debt/Assets
34.3%
Interest Coverage
-40.71x
Long-term Debt
$8.5M

HCTI Revenue & Earnings Growth: 5-Year Financial Trend

HCTI 5-year financial data: Year 2021: Revenue $35.3M, Net Income $2.4M, EPS $0.08. Year 2022: Revenue $45.9M, Net Income -$5.9M, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Healthcare Triangle, Inc.'s revenue has grown significantly by 30% over the 5-year period, indicating strong business expansion. The most recent EPS of $-16,909.30 indicates the company is currently unprofitable.

HCTI Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-69.9%
Free cash flow / Revenue

HCTI Quarterly Earnings & Performance

Quarterly financial performance data for Healthcare Triangle, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q1 2026 $3.7M -$1.7M $-0.17
Q3 2025 $2.4M -$1.2M $-0.42
Q2 2025 $3.0M -$1.4M $-0.58
Q1 2025 $3.7M -$1.7M $-0.17
Q3 2024 $2.4M -$1.2M $-0.22
Q2 2024 $3.0M -$1.5M $-0.28
Q1 2024 $4.1M -$1.9M $-0.42
Q2 2023 $7.8M -$405.0K N/A

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Healthcare Triangle, Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$6.9M
Cash generated from operations
Stock Buybacks
$142.0K
Shares repurchased (TTM)
Capital Expenditures
$22.0K
Investment in assets
Dividends
None
No dividend program

HCTI SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Healthcare Triangle, Inc. (CIK: 0001839285)

📋 Recent SEC Filings

Date Form Document Action
May 14, 2026 10-Q ea0290238-10q_healthcare.htm View →
Apr 16, 2026 10-K/A ea0286705-10ka1_healthcare.htm View →
Apr 15, 2026 10-K ea0284191-10k_healthcare.htm View →
Apr 10, 2026 8-K ea0285959-8k_healthcare.htm View →
Mar 11, 2026 8-K ea0281146-8k_healthcare.htm View →

Frequently Asked Questions about HCTI

What is the AI rating for HCTI?

Healthcare Triangle, Inc. (HCTI) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 80% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are HCTI's key strengths?

Claude: Moderate leverage with Debt/Equity ratio of 0.16x provides some financial flexibility. Positive stockholders equity of $52.7M provides a capital cushion above liabilities. ChatGPT: Triple-digit revenue growth from a low base. Low leverage (0.10x D/E) reduces solvency risk.

What are the risks of investing in HCTI?

Claude: Severe liquidity crisis: current ratio of 0.90x indicates inability to cover short-term obligations; negative operating cash flow of -$6.9M indicates rapid cash depletion with estimated 6-12 month runway. Persistent unprofitability across all levels: operating loss of -$3.6M, net loss of -$6.2M, negative interest coverage of -40.7x indicates inability to service debt from operations. ChatGPT: Severe cash burn vs. $1.63M cash implies short runway. Persistent negative margins and returns (ROE/ROA) indicate weak economics.

What is HCTI's revenue and growth?

Healthcare Triangle, Inc. reported revenue of $9.9M.

Does HCTI pay dividends?

Healthcare Triangle, Inc. does not currently pay dividends.

Where can I find HCTI SEC filings?

Official SEC filings for Healthcare Triangle, Inc. (CIK: 0001839285) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is HCTI's EPS?

Healthcare Triangle, Inc. has a diluted EPS of $-6.81.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is HCTI a good stock to buy right now?

Based on our AI fundamental analysis in May 2026, Healthcare Triangle, Inc. has a STRONG SELL rating with 80% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is HCTI stock overvalued or undervalued?

Valuation metrics for HCTI: ROE of -11.8% (sector avg: 22%), net margin of -62.9% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.

Should I buy HCTI stock in 2026?

Our dual AI analysis gives Healthcare Triangle, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is HCTI's free cash flow?

Healthcare Triangle, Inc.'s operating cash flow is $-6.9M, with capital expenditures of $22.0K. FCF margin is -69.9%.

How does HCTI compare to other Technology stocks?

Vs Technology sector averages: Net margin -62.9% (avg: 18%), ROE -11.8% (avg: 22%), current ratio 0.90 (avg: 2.5).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% DECK 87% NVDA 87%
Sector: All Technology Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 21, 2026 | Data as of: 2026-03-31 | Powered by Claude AI